Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Optimal Biological Dose and Safety Evaluation of the P2Et Extract in Patients With Breast Cancer (Phase I / II)

NCT05007444 is registered in ClinicalTrials.gov with Hospital Universitario San Ignacio as lead sponsor.

NCT NCT05007444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05007444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Optimal Biological Dose and Safety Evaluation of the P2Et Extract in Patients With Breast Cancer (Phase I / II)
Lead sponsor
Hospital Universitario San Ignacio
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2022
Completion date
June 30, 2023
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, quality of life, tumor, breast